アイオワ州における多発性骨髄腫の臨床試験
アイオワ州内の拠点で、多発性骨髄腫に関する17件の研究が参加者を募集しています。
アイオワ州内の都市
公式研究テキスト（英語）
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- University of Iowa Hospitals and Clinics, Iowa City
- Mission Cancer Blood University of Iowa Health Care, Waukee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07518186A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
- Research Site, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07073547A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- University of Iowa Hospital and Clinics, Iowa City
- Mission Cancer Blood, Waukee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07258511A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- University of Iowa Health Care, Waukee
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05552222Collection of Tissue Samples for Cancer Research
- University of Iowa, Iowa City
被験者募集中観察研究
2 Months · 全性別 · 2026/09/16更新 · NCT00900198Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- University of Iowa, Iowa City
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06297226Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- 他18件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/19更新 · NCT04566328AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
- Research Site, Iowa City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05850234Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Research Site, Iowa City
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/14更新 · NCT07764978A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- University of Iowa, Iowa City
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/06更新 · NCT07284758Integrated Cancer Repository for Cancer Research
- Methodist Jennie Edmundson Hospital, Council Bluffs
- Covenant Medical Center, Inc, Waterloo
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Mission Cancer and Blood - Ankeny, Ankeny
- University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf
- Physicians' Clinic of Iowa PC, Cedar Rapids
- 他7件
被験者募集中第3相
全年齢 · 全性別 · 2026/06/10更新 · NCT05561387Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
- University of Iowa, Iowa City
被験者募集中第2相
19歳以上 · 全性別 · 2026/06/04更新 · NCT06974786Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
- University of Iowa Health Care, Iowa City
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/04更新 · NCT07581704Sleep Apnea in Patients With MGUS and MM
- University of Iowa, Iowa City
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2025/11/10更新 · NCT04114084Activity Levels in Bone Marrow Transplant Patients
- University of Iowa, Iowa City
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2025/11/10更新 · NCT04115241Limited-duration Teclistamab
- University of Iowa Hospitals and Clinics, Iowa City
被験者募集中第2相
18歳以上 · 全性別 · 2025/10/01更新 · NCT05932680ClinicalTrials.govより、2026/10/04時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。